Which has grown faster, CI or MRNA?

Over the past five years, MRNA grew revenue faster — CI at a 11.11% CAGR versus MRNA at 19.33%.

Does CI or MRNA pay a bigger dividend?

CI pays a dividend (2.29% yield), while MRNA has no payments in the available dividend history.

Is CI or MRNA more profitable?

CI runs the higher net margin — CI at 2.27% versus MRNA at -141.43%.

How have CI and MRNA total returns compared?

Over the past 5 years, CI delivered 7.94% and MRNA delivered -11.04% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Cigna Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$71.48B

$270.53HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

MRNA

Moderna, Inc.

$75.39B

$190.01HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — CI vs MRNA

growth of $100 · dividends reinvested · last 8y

CI +38.8% (+4.2%/yr)MRNA +921.6% (+33.7%/yr)MRNA compounded faster over this window

Log scale — wide-divergence pair

CI MRNA

CI vs MRNA: by the numbers

•MRNA is the larger company ($75.39B vs $71.48B market cap).
•CI is profitable (2.27% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 11.11% CAGR).
•CI pays a dividend (2.29% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CI	MRNA
P/E ratio	11.20	N/A
Forward P/E	8.87	N/A
P/S ratio	0.25	33.84
P/B ratio	1.68	11.15
EV / EBITDA	7.86	N/A
FCF yield	12.75%	N/A

Profitability

Metric	CI	MRNA
Gross margin	11.66%	55.35%
Operating margin	3.46%	-158.13%
Net margin	2.27%	-141.43%
ROE	15.05%	-46.61%
ROIC	7.69%	-39.16%

Dividends

Metric	CI	MRNA
Dividend yield	2.29%	N/A
Payout ratio	25.62%	N/A

Growth (annualized)

Metric	CI	MRNA
Revenue CAGR (5Y)	11.11%	19.33%
EPS CAGR (5Y)	-0.76%	N/A
FCF CAGR (5Y)	-1.95%	N/A
Total return CAGR (5Y)	7.94%	-11.04%

Frequently asked

Which has grown faster, CI or MRNA?: Over the past five years, MRNA grew revenue faster — CI at a 11.11% CAGR versus MRNA at 19.33%.
Does CI or MRNA pay a bigger dividend?: CI pays a dividend (2.29% yield), while MRNA has no payments in the available dividend history.
Is CI or MRNA more profitable?: CI runs the higher net margin — CI at 2.27% versus MRNA at -141.43%.
How have CI and MRNA total returns compared?: Over the past 5 years, CI delivered 7.94% and MRNA delivered -11.04% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Cigna dividend yield Cigna ROE Moderna ROE Cigna operating margin Moderna operating margin Cigna revenue growth Moderna revenue growth Cigna free cash flow Moderna free cash flow

Cigna & Moderna appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.